The administration of PACs alleviated HFHS-mediated dyslipidemia, with an elevated trend in levels of HDL-cholesterol ( Figure 3 F). 3.4.
← all excerpts
Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders.
1
—
—